Nemaura Launches New Metabolic Health Program; Biocon Receives More Form 483 Observations; Virta Health Key Leadership Appointments; Dexcom G6 Coverage in Manitoba; EASD 2021 Key Press Releases (Sept 29)

On the third day of EASD 2021, four key press releases were observed from Nemaura, Biocon, Virta Health, and Dexcom. Below FENIX provides insights and context for the respective announcements.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.